PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för Breo Ellipta. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

11 hits

Bibliografisk träff 2013-10-01

Efficacy and safety of fluticasone furoate/vilanterol compared with fluticasone propionate/salmeterol combination in adult and adolescent patients with persistent asthma: a randomized trial.

Woodcock A, Bleecker ER, Lötvall J, O'Byrne PM, Bateman ED, Medley H, Ellsworth A, Jacques L, Busse WW.

Chest · comparative study; research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1378/chest.13-0178

Bibliografisk träff 2013-07-02

Systemic safety of fluticasone furoate/vilanterol combination.

Lipworth B.

Thorax · letter; comment · DOI 10.1136/thoraxjnl-2013-203910

Bibliografisk träff 2013-06-05

Inhaled fluticasone furoate/vilanterol does not affect hypothalamic-pituitary-adrenal axis function in adolescent and adult asthma: randomised, double-blind, placebo-controlled study.

Allen A, Schenkenberger I, Trivedi R, Cole J, Hicks W, Gul N, Jacques L.

Clin Respir J · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1111/crj.12026

Bibliografisk träff 2013-01-23

A randomised trial of fluticasone furoate/vilanterol (50/25 μg; 100/25 μg) on lung function in COPD.

Kerwin EM, Scott-Wilson C, Sanford L, Rennard S, Agusti A, Barnes N, Crim C.

Respir Med · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.rmed.2012.12.014

Bibliografisk träff 2013-01-16

Fluticasone furoate/vilanterol (100/25; 200/25 μg) improves lung function in COPD: a randomised trial.

Martinez FJ, Boscia J, Feldman G, Scott-Wilson C, Kilbride S, Fabbri L, Crim C, Calverley PM.

Respir Med · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.rmed.2012.12.016

Bibliografisk träff 2012-12-01

Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.

Tamm M, Richards DH, Beghé B, Fabbri L.

Respir Med · research support, non-u.s. gov't; review; journal article · DOI 10.1016/s0954-6111(12)70005-7

Bibliografisk träff 2012-11-30

Influence of renal and hepatic impairment on the pharmacokinetic and pharmacodynamic properties and tolerability of fluticasone furoate and vilanterol in combination.

Allen A, Davis A, Hardes K, Tombs L, Kempsford R.

Clin Ther · controlled clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1016/j.clinthera.2012.11.001

Bibliografisk träff 2012-09-27

The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol.

Vestbo J, Anderson J, Brook RD, Calverley PM, Celli BR, Crim C, Haumann B, Martinez FJ, Yates J, Newby DE.

Eur Respir J · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1183/09031936.00087312

Bibliografisk träff 2012-07-11

Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.

Boscia JA, Pudi KK, Zvarich MT, Sanford L, Siederer SK, Crim C.

Clin Ther · clinical trial, phase iii; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.clinthera.2012.06.005

Bibliografisk träff 2012-06-27

Combined fluticasone furoate/vilanterol reduces decline in lung function following inhaled allergen 23 h after dosing in adult asthma: a randomised, controlled trial.

Oliver A, Quinn D, Goldfrad C, van Hecke B, Ayer J, Boyce M.

Clin Transl Allergy · research-article; journal article · DOI 10.1186/2045-7022-2-11

Bibliografisk träff 2012-01-19

Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial.

Lötvall J, Bakke PS, Bjermer L, Steinshamn S, Scott-Wilson C, Crim C, Sanford L, Haumann B.

BMJ Open · research-article; journal article · DOI 10.1136/bmjopen-2011-000370